Prophylactic Antiasthma Drugs in Japan

References

• Bernstein I L., Hargreave F E., Nicklas R A., Reed C E. Synopsis of guidelines for the evaluation of NBAAD. Report of the American Academy of Allergy and Immunology task force on guidelines for clinical investigations of nonhronchodilator antiasthmatic drugs. J Allergy Clin Immunol 1986; 78: 491, 493
   Web of Science ®Google Scholar
• Kaliner M. Mast cell mediators and asthma. Prog Resp Res 1985; 19: 17, 29
   Google Scholar
• Wasserman S I. Mediators of immediate hypersensitivity. J Allergy Clin Immunol 1983; 72: 101, 115
   PubMed Web of Science ®Google Scholar
• Holgate S T., Hardy C, Robinson C. The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol 1986; 77: 274, 282
   PubMed Web of Science ®Google Scholar
• Ishizaka T. Analysis of triggering events in mast cells for immunoglobulin E-mediated histamine release. J Allergy Clin Immunol 1981; 67: 90, 96
   PubMed Web of Science ®Google Scholar
• Kurosawa M. Protein phosphorylation and inositol phospholipid metabolism in activated mast cells. Clin Exp Allergy 1990; 20: 7, 12
   PubMed Web of Science ®Google Scholar
• Stan worth D R. The role of non-antigen receptors in mast cells signalling process. Mol Immunol 1984; 21: 1183, 1190
   PubMed Web of Science ®Google Scholar
• Kay A B. Mediators and inflammatory cells in asthma. Asthma. Clinical Pharmacology and Therapeutic Progress, A B Kay. Blackwell Scientific Publications, Oxford 1986; 1–10
   Google Scholar
• Chung K F. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 1986; 41: 657, 662
   PubMed Web of Science ®Google Scholar
• Barnes P J. Asthma as an axon reflex. Lancet 1986; 7: 242, 245
   Google Scholar
• Booij-Noord H, Orie N GM, de Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy 1971; 48: 344, 354
   Google Scholar
• Koda A, Nagai H, Watanabe S. Inhibition of hypersensitivity reactions by a new drug, N-(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′). J Allergy Clin Immunol 1976; 57: 396, 407
   PubMed Web of Science ®Google Scholar
• Azuma H, Banno K, Yoshimura T. Pharmacological properties of N-(3′,4′-dimethyoxycinnamoyl) anthranilic acid (N-5′), a new anti-atopic agent. Br J Pharmacol 1976; 58: 483, 486
   PubMed Web of Science ®Google Scholar
• Shioda H, Nakayama Y, Murano J. Efficacy of N-5′ in the treatment of bronchial asthma in children by a multi-center, double-blind study (translated from Japanese). Jap J Pediatr 1978; 31: 2514, 2526, (in Japanese)
   Google Scholar
• Yakura T, Shida T, Yamamura Y. Efficacy of an anti-allergic agent N-5′ in the treatment of bronchial asthma by a multi-center, double-blind study in comparison with disodium cromoglycate and a placebo (translated from Japanese). Med Consult New Remedies 1982; 19: 529, 572, (in Japanese)
   Google Scholar
• Craps L. The prophylaxis of bronchial asthma with ketotifen: five years of clinical investigations. Acta Therapeutica 1980; 6: 213, 225
   Google Scholar
• Kumagai A, Takahashi T, Shida T. Clinical evaluation of HC 20-511 (ketotifen), a new orally anti-anaphylactic compound, in bronchial asthma. Clin Eval 1980; 8: 353, 396, (in Japanese)
   Google Scholar
• Yamamura Y, Mitsui S, Suto M. The items decided by the Study Group in Japanese Society of Allergology on the severity of bronchial asthma (translated from Japanese). Jpn J Allergol 1983; 32: 1186, 1199, (in Japanese)
   Google Scholar
• Kumagai A, Takahashi T, Shida T. Clinical evaluation of HC 20-511 (ketotifen), a new oral anti-anaphylactic compound, in bronchial asthma. II. Multi-center double-blind study in comparison with disodium cromoglycate. Clin Eval 1982; 10: 737, 785, (in Japanese)
   Google Scholar
• Tinkelman D G., Webb S C., Vanderpool G E. The use of ketotifen in the prophylaxis of season allergic asthma. Ann Allergy 1986; 56: 213, 217
   PubMedGoogle Scholar
• Katayama S, Akimoto N, Shionoya H. Antiallergic effects of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro. Arzneim-Forsch 1981; 31: 1196, 1203
   PubMed Web of Science ®Google Scholar
• Makino S, Ishizaki T, Nagano H. Clinical study about the efficacy of E-0659 (azelastine) in bronchial asthma by a multi-center, double-blind study in comparison with ketotifen (translated from Japanese). Jap J Clin Exp Med 1986; 63: 609, 635, (in Japanese)
   Google Scholar
• Busse W, Randlev B, Sedgwick J. The effect of azelastine on neutrophil and eosinophil generation of superoxide. J Allergy Clin Immunol 1989; 83: 400, 405
   PubMed Web of Science ®Google Scholar
• Kurosawa M, Hanawa K, Kobayashi S. Inhibitory effects of azelastine on superoxide anion (O2-) generation from activated inflammatory cells measured by a simple chemiluminescence method. Arzneim-forsch 1990; 40: 767, 770
   PubMed Web of Science ®Google Scholar
• Nakamura T, Kusakawa S, Mikawa H. Clinical efficacy of a new oral anti-allergic agent oxatomide dry syrup in the treatment of bronchial asthma in children by a multi-center, double-blind study (translated from Japanese). Jap J Pediatr 1985; 38: 423, 435, (in Japanese)
   Google Scholar
• Kishimoto S, Miyamoto T, Shida T. Efficacy of amlexanox (AA-673) tablet in the treatment of bronchial asthma by a multi-center, double blind study in comparison with tranilast (translated from Japanese). Igaku no Ayumi 1986; 138: 1005, 1030, (in Japanese)
   Google Scholar
• Miyamoto T, Takahashi T, Shida T. Clinical efficacy of a new anti-allergic agent MY-5116 in the treatment of bronchial asthma by a multi-center, double-blind study in comparison with tranilast (translated from Japanese). Med Consult New Remedies 1986; 23: 251, 276, (in Japanese)
   Google Scholar
• Takahashi T, Kawakami Y, Takishima T. Clinical evaluation of KC 404, a new anti-asthmatic agent, in the treatment of bronchial asthma Multi-center double-blind study in comparison with tranilast. Clin Eval 1986; 14: 373, 407, (in Japanese)
   Google Scholar
• Tasaka K, Akagi M, Mio M. Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells. Int Arch Allergy Appl Immunol 1987; 83: 348, 353
   PubMedGoogle Scholar
• Saijo T, Makino H, Tamura S. The antiallergic agent amoxanox suppresses SRS-A generation by inhibiting lipoxygenase. Int Arch Allergy Appl Immunol 1986; 79: 231, 237
   PubMedGoogle Scholar
• Takahashi K, Yamada N, Yasumura K. Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic agent, on the release of mediators from guinea pig lung fragments. Jpn JAllergol 1986; 35: 982, 987
   PubMedGoogle Scholar
• Ohashi M, Kanai R, Nishino K. Antagonistic effect of KC404, a new anti-allergic agent, on leukotriene D4 induced contractile responses in isolated guinea pig smooth muscles. Prostaglandins 1986; 32: 875, 888
   PubMed Web of Science ®Google Scholar
• Sheffer A L., Buist A S., Nicklas R A. Proceedings of the Asthma Mortality Task Force. J Allergy Clin Immunol 1987; 80: 361, 514
   PubMed Web of Science ®Google Scholar
• Mitsui S. Death from bronchial asthma in Japan. Sino-Jpn J Allergol Immunol 1986; 3: 249, 257
   Google Scholar